Evidence map›Paper›PMID 40980910›Full record

ArticleAntimicrobial agents and chemotherapy2025

Emergence of azithromycin and ciprofloxacin non-susceptible genotype 4.2.2

Ashwini Vinod, Andrew J Hayes, Yogeshni Chandra, Sonika Kaajal Nair, Tashyam Pillay, Farieya Fayza Khan, Shalini Goundar, Luse Dulaki Kalou, Khushnuma Khan, Maria Borua Anise and 13 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Azithromycin-resistantJAC-antimicrobial resistance · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Ashwini VinodLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Andrew J HayesDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Yogeshni ChandraLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Sonika Kaajal NairLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Tashyam PillayLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Farieya Fayza KhanLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Shalini GoundarLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Luse Dulaki KalouLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Khushnuma KhanLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Maria Borua AniseLautoka Hospital, Aspen Medical Health Care Fiji limited, Lautoka, Fiji.
Mary ValcanisMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Xinwei RuanDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Shalini SinghFiji Centre for Disease Control, Ministry of Health and Medical Services, Suva, Fiji.
Jessica BarndenMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Raphaël M ZellwegerInternational Vaccine Institute, Seoul, South Korea.
Alumita VuakanisakeaLive and Learn Environmental Education, Suva, Fiji.
Kylie HuiMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Lisa J IoannidisDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Kim MulhollandMurdoch Childrens Research Institute, Melbourne, Australia.
Richard A StrugnellMurdoch Childrens Research Institute, Melbourne, Australia.
Benjamin P HowdenDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Mark R Davies *Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0001-6141-5179
Aneley Getahun Strobel *Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-8425-6497

Funding

University of Melbourne NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcrB mutationantimicrobial resistanceCiprofloxacin resistanceFijigenomic epidemiologyOceaniaSalmonella TyphiTyphoid

Identifiers

PMID40980910
PMCPMC12587616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.